Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.
Zacks.com on MSN
Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Agilent Technologies (A). Shares have added about 9.6% in that ...
Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell ...
Agilent Technologies has delivered a solid share price run over recent years, and the question now is whether the current ...
Agilent Technologies stock (ISIN US00846U1016) closed at USD 167.83 on the NYSE on October 2, 2026, up 0.69 percent for the ...
SANTA CLARA, Calif. -- (BUSINESS WIRE)--Sep. 29, 2026-- Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis ...
Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual ...
Agilent Technologies (NYSE: A) has launched two new automated electrophoresis systems and accompanying software designed for clinical next-generation sequencing (NGS) sample quality control in ...
Agilent Technologies (A) has an average rating of overweight and mean price target of $179.61, according to analysts polled by FactSet.
The new space complements established solid-phase synthesis operations, giving Agilent's Advanced Therapeutics Division a dedicated environment to develop solvent-free enzymatic manufacturing approach ...
Validation of HALO's Advanced Security Screening Technology Agilent Technologies, Inc. has led a multimillion dollar investment round in which other existing Blue Chip investors UK Innovation Science ...
Agilent Technologies Inc. operates as a global provider of laboratory instruments, diagnostics and services, with its shares reflecting expectations for steady demand from life sciences, chemical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results